Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022

Rhea-AI Summary

Modular Medical, Inc. (NASDAQ:MODD) will present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022, at 1:00 p.m. ET. CEO Jeb Besser will discuss the company’s innovative insulin delivery technology aimed at making insulin pumps more affordable and user-friendly. The event will include one-on-one meetings with investors, and interested parties can view the presentation live or as a replay. Modular Medical aims to revolutionize diabetes management with its patented technologies, enhancing access to effective glycemic control.

SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, CEO, is scheduled to present at the Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022 at 1:00 p.m. ET. Mr. Besser will also host meetings with participating investors throughout the day during this virtual event. The presentation will be webcast live and available for replay: here.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.wright@issuerdirect.com. Investors can also register here.

About the MicroCap Rodeo Spring Into Action Best Ideas Conference
The MicroCap Rodeo is back with its "Best Ideas Bowl." This conference is a virtual conference that brings you the top 36 best ideas. Qualified institutional investors recommended each of the 36 companies represented as one of their best ideas. Those of you who attended the 2019 MicroCap Rodeo in Austin, Texas, know that we're focused on alpha.

About Modular Medical

Modular Medical, Inc. (NASDAQ:MODD) intends to launch the first next generation of insulin delivery technology that will be both affordable and simple enough to learn and use to transform the insulin pump market into a mass market. Our patented technologies will eliminate the tradeoff between complexity and efficacy and seek to set new standards for insulin dosing that most closely mimics nature. Our mission is to improve access to the highest standards of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us." Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and renowned microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes (TNDM) and invented and designed its t:slim insulin pump.

Contact:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.

View source version on accesswire.com:
https://www.accesswire.com/701163/Modular-Medical-to-Present-at-Spring-Into-Action--Best-Ideas-Virtual-Investor-Conference-on-May-18-2022

FAQ

What is the date and time of Modular Medical's presentation at the investor conference?

Modular Medical will present on May 18, 2022, at 1:00 p.m. ET.

Who is the CEO of Modular Medical?

The CEO of Modular Medical is Jeb Besser.

Where can I watch the Modular Medical presentation?

The presentation will be webcast live and available for replay, with details provided in the press release.

What is the focus of Modular Medical's technology?

Modular Medical focuses on creating affordable and easy-to-use insulin delivery technology.

What is the purpose of the Spring Into Action conference?

The conference features top investment ideas recommended by qualified institutional investors.